BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03834493-completion@plaintrial.com
DTSTAMP:20261027T152931Z
DTSTART;VALUE=DATE:20260529
SUMMARY:Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo P
 lus Enzalutamide in Participants With Metastatic Castration-resistant Pros
 tate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641) — estimated completion dat
 e
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT03834493
URL:https://plaintrial.com/trial/NCT03834493
END:VEVENT
END:VCALENDAR